Muutke küpsiste eelistusi

Cognitive Behavioral Therapy for Insomnia: A Session by Session Guide Second Edition 2026 [Kõva köide]

  • Formaat: Hardback, 229 pages, kõrgus x laius: 235x155 mm, 11 Illustrations, color; 1 Illustrations, black and white
  • Ilmumisaeg: 10-Jun-2026
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3032198062
  • ISBN-13: 9783032198068
  • Kõva köide
  • Hind: 108,52 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 144,69 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 229 pages, kõrgus x laius: 235x155 mm, 11 Illustrations, color; 1 Illustrations, black and white
  • Ilmumisaeg: 10-Jun-2026
  • Kirjastus: Springer Nature Switzerland AG
  • ISBN-10: 3032198062
  • ISBN-13: 9783032198068
This second edition updates our 2005 book. While the original continues to attract interest due to its concise yet comprehensive format, the aggregation of 21 years of research on cognitive behavioral therapy for insomnia (CBT-I) has substantially transformed the field. Most notably, insomnia has been reconceptualized. In 2005, insomnia was typically viewed as a symptom of other primary disorders, leading to two assumptions: (1) that treating the primary disorder would resolve insomnia, and (2) that behavioral treatment of insomnia in the presence of comorbidity would be ineffective. As a result, CBT-I was reserved for relatively rare cases of uncomplicated insomnia. These assumptions have now been debunked.



Research demonstrates that chronic insomnia frequently persists despite successful treatment of comorbid conditions and that CBT-I is nearly as effective for comorbid insomnia as it is for uncomplicated insomnia. More, CBT-I has meaningful halo effects, with responders often showing significant improvements in comorbid conditions. In depression, CBT-I outcomes may rival those of antidepressant medications or CBT for depression alone. Collectively, these findings support directly targeting chronic insomnia and the recommendation that CBT-I be a first-line therapy. This position has been codified by the American College of Physicians and endorsed by numerous professional organizations worldwide. We further argue that there is great clinical value to, when possible, treating insomnia first, as a gateway therapy that facilitates broader clinical improvement. Finally, this edition integrates over two decades of additional clinical experience, enriching both the clinical guidance and patient-centered communication presented throughout the manual. About the Authors (from the text).
The Definition of Insomnia.- The Conceptual Framework for CBT-I.- The
Components of Therapy.- CBT-I Session by Session.- CBT-I Example Dialogues
for Patient Questions and Challenges.- A Case Example.
Donn A. Posner PhD CBSM DBSM



Dr. Posner is the Founder and President of Sleepwell Consultants and has been consulting to organizations and individuals on a wide variety of sleep health issues including insomnia, circadian dysrhythmia, CPAP adherence, and parasomnias. He continues to operate a small clinical practice in Behavioral Sleep Medicine and is a licensed psychologist in California, Massachusetts, New Hampshire, Pennsylvania, and Rhode Island. He is also currently an Adjunct Clinical Associate Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and a consulting psychologist, for the Palo Alto VA. Prior to this he spent 25 years serving as the Director of Behavioral Sleep Medicine for the Sleep Disorders Center of Lifespan Hospitals, and was a Clinical Associate Professor in the Department of Psychiatry and Human Behavior at the Warren Alpert School of Medicine at Brown University. Dr. Posner is a member of the American Academy of Sleep Medicine and is one of the first Certified Behavioral Sleep Medicine specialists recognized by that group. He is also a founding member of the Society of Behavioral Sleep Medicine and he has also now achieved the status of Diplomate with the Board of Behavioral Sleep Medicine (BBSM).



Michael L. Perlis PhD FSBSM



Dr. Perlis is an Associate Professor of Psychiatry & Nursing at the University of Pennsylvania. He is also the Director of the Penn Behavioral Sleep Medicine program. His clinical expertise is in the area of insomnia disorder. His research interests include sleep in psychiatric disorders, nocturnal wakefulness as a risk factor for suicidality, neurocognitive phenomena in insomnia, and the mechanisms of placebos and sedative hypnotics. Dr. Perlis is a coauthor of the first textbook in the area of Behavioral Sleep Medicine (BSM), he is the senior author of the 1st edition of his groups CBT-I treatment manual, and a larger text summarizing all BSM treatments. He co-leads two annual CBT-I training workshops (the basic workshop has been ongoing since 2005 [ w/ Donn Posner] and the advanced workshop has been ongoing since 2014 [ with Donn Posner and Jason Ellis]), has available a mock case vignette DVD, and offers a mini-fellowship BSM practica and supervision through his group at Penn. Note: The Basic CBT-I workshop has also been provided (on request) in England, Sweden, South Africa, Israel, Qatar, Hong Kong, Korea, Japan and Thailand; and the CBT-I manual has been translated into Spanish, Italian, Korean, Mandarin Chinese and Arabic. Dr. Perlis serves on the editorial boards of Sleep, the Journal of Sleep Research, the journal of Sleep Medicine Research, and the journal of Behavioral Sleep Medicine. Dr. Perlis has also served as a member, or chair, of several committees and task forces of the Sleep Research Society and the American Academy of Sleep Medicine and he was the assistant chair for the training program of the SRS for five years. Finally, Dr. Perlis was one of the five organizing and founding members of the Society of Behavioral Sleep Medicine (SBSM). He also served as the SBSMs first president.



Michael A. Grandner PhD MTR CBSM DBSM FSBSM FAASM FAHA



Dr. Grandner is a licensed clinical psychologist board certified in Behavioral Sleep Medicine. He is the Director of the Sleep and Health Research Program at the University of Arizona College of Medicine Tucson, Associate Professor of Psychiatry, Medicine, Psychology, Nutritional Sciences, and Clinical and Translational Science, and Director of the Behavioral Sleep and Circadian Medicine Clinic at the Banner-University Medical Center in Tucson, AZ. He is a past President of the Society of Behavioral Sleep Medicine, author/co-author of over 300 academic publications on the topic of sleep health, and editor / co-editor of textbooks on Sleep and Health, Adapting Cognitive Behavioral Therapy for Insomnia, and Sleep and Sport. He is an elected fellow of the Society of Behavioral Sleep Medicine, American Academy of Sleep Medicine, and American Heart Association. He also was the inaugural chair of the AHAs sleep science committee and a co-author of the AHAs Lifes Essential 8 framework. He has also led / contributed to position statements from the Sleep Research Society American Academy of Sleep Medicine, Society of Behavioral Sleep Medicine, National Institutes of Health, National Collegiate Athletics Association, International Olympic Committee, American College of Sports Medicine, and others. He has won numerous awards for his work, has served on many national committees, and regularly consults with technology, health, nutrition, and athletics organizations.



Michael T. Smith PhD CBSM DBSM FSBSM



Dr. Smith is Professor of Psychiatry, Neurology and Nursing at Johns Hopkins University School of Medicine where he serves as Vice Chair for Faculty in the Department of Psychiatry and as the Director of the Behavioral Medicine Division. He is a practicing clinical psychologist and researcher. Dr. Smith founded the Johns Hopkins Behavioral Sleep Medicine Program in 2001 and is a co-founder and Past President of the Society of Behavioral Sleep Medicine. Dr. Smiths 21-year history of continuously NIH funded research focuses on the neurobehavioral causes, consequences, and treatments of insomnia and sleep loss with an emphasis on the interface between sleep and pain.